The Dubai Effect
This article was originally published in RPM Report
The Dubai ports deal controversy has Congress on the prowl for any foreign investment in the US that could raise a red flag. Lawmakers want to look tough on national security more than ever during an election year. A more restrictive environment on Capitol Hill may spill over to certain sectors of biopharma mergers and acquisitions.
You may also be interested in...
The intensely negative advisory committee for Biogen’s proposed Alzheimer’s therapy was a shocker. Would it have happened if US FDA had been able to convene an in-person event instead of a ‘virtual’ one?
With landmark advisory committee meetings coming up, we take a look back at some of the memorable panel meetings over the last 20 years.
With landmark advisory committee meetings coming up, we take a look back at some of the memorable panel meetings over the last 20 years. This is Part II in the series.